Medicare Enrolled

Dr. Aron Simkins, M.D.

Hematology & Oncology · Miami Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
4306 ALTON RD, Miami Beach, FL 33140
3055353349
In practice since 2015 (10 years)
NPI: 1093197931 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Simkins from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Simkins? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Simkins

Dr. Aron Simkins is a hematology & oncology in Miami Beach, FL, with 10 years in practice. Based on federal Medicare data, Dr. Simkins performed 458 Medicare services across 264 unique beneficiaries.

Between the years covered by Open Payments, Dr. Simkins received a total of $42,542 from 79 pharmaceutical and/or device companies across 780 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Simkins is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice▲ 458 Medicare services$ $42,542 industry payments

Medicare Practice Summary

Medicare Utilization ↗
458
Medicare services
Bottom 42% in FL for hematology & oncology
264
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~46 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)170$55$175
Office visit, established patient (30-39 min)141$82$274
New patient office visit (45-59 min)50$110$456
Blood draw (venipuncture)39$8$9
Initial hospital admission, high complexity33$140$652
Hospital follow-up visit, moderate complexity25$68$228
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$42,542
Total received (2018-2024)
Avg $6,077/year across 7 years
Top 16% in FL for hematology & oncology
79
Companies
780
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24,944 (58.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,307 (36.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,291 (5.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$30,983
2023
$6,354
2022
$3,792
2021
$759
2020
$138
2019
$321
2018
$196

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$27,150
Janssen Biotech, Inc.
$1,162
Celgene Corporation
$1,065
Merck Sharp & Dohme LLC
$853
AstraZeneca Pharmaceuticals LP
$850
PFIZER INC.
$828
Daiichi Sankyo Inc.
$745
Novartis Pharmaceuticals Corporation
$635
Astellas Pharma US Inc
$535
Incyte Corporation
$497
Genentech USA, Inc.
$451
BeiGene USA, Inc.
$368
Myriad Genetic Laboratories, Inc.
$321
Sumitomo Pharma America, Inc.
$305
Amgen Inc.
$294
Tempus AI, Inc
$285
ABBVIE INC.
$268
ARRAY BIOPHARMA INC
$245
Boehringer Ingelheim Pharmaceuticals, Inc.
$233
Regeneron Healthcare Solutions, Inc.
$230
E.R. Squibb & Sons, L.L.C.
$230
Takeda Pharmaceuticals U.S.A., Inc.
$227
Seagen Inc.
$223
GENZYME CORPORATION
$218
AbbVie Inc.
$212
EMD Serono, Inc.
$210
Deciphera Pharmaceuticals Inc.
$195
Sirtex Medical Inc
$191
Exelixis Inc.
$189
Bayer Healthcare Pharmaceuticals Inc.
$185
Mirati Therapeutics, Inc.
$169
SOBI, INC
$161
Genmab U.S., Inc.
$161
Agios Pharmaceuticals, Inc.
$159
TAIHO ONCOLOGY, INC.
$150
Adaptive Biotechnologies Corporation
$145
JAZZ PHARMACEUTICALS INC.
$143
Rigel Pharmaceuticals, Inc.
$137
EISAI INC.
$129
Lilly USA, LLC
$124
SpringWorks Therapeutics, Inc.
$108
Pharmacosmos Therapeutics Inc.
$94
ADC Therapeutics America, Inc.
$94
SERVIER PHARMACEUTICALS LLC
$93
Ipsen Biopharmaceuticals, Inc
$89
Stemline Therapeutics Inc.
$83
Foundation Medicine, Inc.
$76
GlaxoSmithKline, LLC.
$76
MorphoSys, US Inc.
$71
Merck Sharp & Dohme Corporation
$66
CTI BioPharma Corp.
$58
Bayer HealthCare Pharmaceuticals Inc.
$52
Epizyme, Inc.
$45
Kyowa Kirin, Inc.
$45
Abbott Laboratories
$43
Pharmacyclics LLC, an AbbVie Company
$40
Pharmacyclics LLC, An AbbVie Company
$40
AVEO Pharmaceuticals, Inc.
$40
Gilead Sciences, Inc.
$38
Janssen Pharmaceuticals, Inc
$33
Alexion Pharmaceuticals, Inc.
$32
Blueprint Medicines Corporation
$29
ImmunoGen, Inc.
$25
Epizyme, Inc.,
$24
Myovant Sciences Inc.
$24
Dendreon Pharmaceuticals LLC
$23
Puma Biotechnology, Inc.
$21
RECORDATI_RARE_DISEASES_INC.
$21
G1 Therapeutics, Inc.
$20
TerSera Therapeutics LLC
$20
Blue Earth Diagnostics Limited
$20
Clovis Oncology, Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$17
Tolmar, Inc.
$17
TOLMAR Pharmaceuticals, Inc.
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Coloplast Corp
$15
Fennec Pharmaceuticals, Inc.
$14
AngioDynamics, Inc.
$14
Top 3 companies account for 69.1% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKEEGA · AYVAKIT · Alecensa · Axumin · BAVENCIO · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CREON · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELITEK · ENHERTU · EPKINLY · ERLEADA · Elahere · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · FREESTYLE LIBRE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LINZESS · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MAVYRET · MEKINIST · MITRACLIP · MONJUVI · MONOFERRIC · MYRISK · NANOKNIFE · NERLYNX · NINLARO · Nplate · Nubeqa · OGSIVEO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROLARIS · PROVENGE · Padcev · Pedmark · Pomalyst · PreciseTumor · Prolaris · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · Rubraca · SARCLISA · SIR-Spheres Microspheres · SYLVANT · SpeediCath · Stivarga · TABRECTA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TRELEGY ELLIPTA · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VIBERZI · Venclexta · Vonjo · WAINUA · XALKORI · XARELTO · XIFAXAN · XT CDX · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (59%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $9,289 per 100 Medicare services performed
Looking for a hematology & oncology in Miami Beach?
Compare hematology & oncologys in the Miami Beach area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
181
Per 100K population
6.7
County median income
$68,694
Nearest hospital
MOUNT SINAI MEDICAL CENTER OF FLORIDA, INC
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Simkins is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 16%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Simkins experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Simkins performed 170 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Simkins receive payments from pharmaceutical companies?
Yes. Dr. Simkins received a total of $42,542 from 79 companies across 780 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Simkins's costs compare to other hematology & oncologys in Miami Beach?
Dr. Simkins's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Simkins) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →